Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia

NCT04607252 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped Our clinical trial NCT03241888 showed LNG-IUS had a better treatment efficacy than Megestrol Acetate (MA) alone. The median CR time for MA group, LNG-IUS group and MA plus LNG-IUS group was 7.0±0.3 months, 4.4±1.0 months and 5.7±1.2 months.

Conditions

Interventions

Sponsor

Fudan University